U.S. FDA approves Johnson & Johnson's bladder cancer drug
The U.S. Food and Drug Administration on Friday approved Johnson & Johnson's treatment for patients with a form of bladder cancer.
from Reuters: Health News https://reut.rs/2X44asA
http://bit.ly/2zwRqiM
April 12, 2019
|
Labels:
health,
Reuters: Health News
|
This entry was posted on April 12, 2019
and is filed under
health
,
Reuters: Health News
.
You can follow any responses to this entry through
the RSS 2.0 feed.
or trackback from your own site.